Table 5.
Summary of metaregression analysis outputs for the variables that influenced the proportion of fever and two more symptoms at suspicious patients of leptospirosis.
| Variable | Estimate |
95% Confidence
interval |
P -value |
|---|---|---|---|
| Intercept | 1.2112 | 0.6162; 1.8063 | <0.0001 |
| Cross-sectional design | −0.4977 | −0.9996; 0.0042 | 0.0519 |
| Longitudinal design | −0.4417 | −0.9374; 0.0540 | 0.0807 |
| Asia | −0.1736 | −0.5625; 0.2153 | 0.3817 |
| Europe | 0.1286 | −0.2859; 0.5431 | 0.5431 |
| Latin-American and Caribbean | −0.0075 | −0.3493; 0.3342 | 0.9655 |
| Serologic and molecular test | 0.1421 | −0.1940; 0.4783 | 0.4073 |
| N | −0.0001 | −0.0002; −0.0000 | 0.0117 |
| Positive Leptospira patients | 0.0002 | −0.0004; 0.0009 | 0.4356 |
tau∧2 (estimated amount of residual heterogeneity): 0.0649 (SE = 0.0260).
tau (square root of estimated tau∧2 value): 0.2547.
I∧2 (residual heterogeneity/unaccounted variability): 98.69%.
H∧2(unaccounted variability/sampling variability): 76.14.
R∧2(amount of heterogeneity accounted for): 9.69%.
Test for Residual Heterogeneity: QE(df = 13) = 1239.4682, p-val < 0.0001.
Test of Moderators (coefficient(s) 2:9): QM(df = 8) = 10.1535, p-val = 0.2544.